| Delirium (n = 13) | Non-delirious (n = 126) | t/ x2 | p |
---|---|---|---|---|
Age, M (SD) | 79.5 (6.0) | 70.6 (13.7) | 4.34 | .000** |
Years of education, M (SD) | 12.5 (3.5) | 13.9 (3.4) | −1.43 | .15 |
Gender, n female (%) | 6 (46%) | 62 (49%) | .04 | .84 |
NIHSS at baslinea, M (SD) | 4.5 (4.6) | 2.8 (3.8) | 1.35 | .17 |
MoCA at baselineb, M (SD) | 20.0 (2.2) | 25.1 (4.7) | −3.10 | .002** |
Premorbid dementia, n (%) | 0 | 2 | .19 | .91 |
Complicationsc > 0, n (%) | 7 (54.6) | 27 (21.4) | −2.15 | .05 |
Charlson Comorbidity Index (CCI), M (SD) | 4.1 (1.3) | 3.6 (1.9) | −1.20 | .24 |
Global Deterioration Scale (GDS) < 3d | ||||
 Pre-stroke, n (%) | 12 (92%) | 124 (98%) | .19 | .66 |
 3 months, n (%) | 4 (30%) | 5 (4%) | 14.0 | .003** |
 18 months, n (%) | 4 (31%) | 11 (9%) | 5.9 | .024* |
 36 months, n (%) | 3 (23%) | 10 (8%) | 3.2 | .079 |
Moderate to severe aphasiae | ||||
 Baseline, n (%) | 3 (23%) | 19 (15%) | .57 | 0.57 |
 3 months, n (%) | 0 | 4 (3%) | .42 | 0.68 |
 18 months, n (%) | 0 | 3 (2%) | .32 | 0.81 |
 36 months, n (%) | 0 | 0 | 0 | 1.0 |